Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04680013 · ClinicalTrials.gov registry record
Genetic Studies in Familial Dementia
A clinical trial of Mild Cognitive Impairment and Dementia, sponsored by University of Miami.
- Completed
- Registry status
- 4,884
- Enrollment target
- 1
- Study location
NCT04680013 is a study of Mild Cognitive Impairment and Dementia that has completed, run by University of Miami. The registered enrollment target is 4,884 participants, above the 1,247-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (292% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04680013, a study of Mild Cognitive Impairment and Dementia, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 4,884 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genetic factors that contribute to or cause dementia (loss of memory) and related disorders across all ages and ethnic groups. This includes a number of neurological diseases such as early and late-onset Alzheimer disease, mild cognitive impairment, and other dementias.
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,884 participants |
| Start Date | 2007-06-01 |
| Est. Completion | 2024-10-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04680013
The ClinicalTrials.gov registry entry for NCT04680013 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,884 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,247-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (292% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 0 interventions.
NCT04680013 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04680013 about?
NCT04680013 is a clinical study titled "Genetic Studies in Familial Dementia". The purpose of this study is to identify genetic factors that contribute to or cause dementia (loss of memory) and related disorders across all ages and ethnic groups. This includes a number of neurological diseases such as early and late-onset Alzheimer disease, mild cognitive impairment, and other...
What is the current status of trial NCT04680013?
This trial is currently completed. The enrollment target is 4,884 participants. The study started on 2007-06-01. Estimated completion is 2024-10-29.
What conditions does trial NCT04680013 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Alzheimer Disease, Early Onset, Dementia of Alzheimer Type, Alzheimer Disease, Late Onset.
Who is sponsoring clinical trial NCT04680013?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04680013 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.